doc.ai, a Palo Alto-based company, is aiming to disrupt the existing healthcare sector by creating an advanced natural language dialog system that generates insights from combined medical data.

The startup came out of stealth mode last month and announced the launch of its advanced natural language processing technology platform using the blockchain to timestamp its datasets and decentralize artificial intelligence.

Walter De Brouwer, founder and chief executive officer of doc.ai, said:

"We are making it possible for lab tests to converse directly with patients by leveraging advanced artificial intelligence, medical data forensics, and the decentralized blockchain. We envision extensive possibilities for the use of this technology by doctors, patients, and medical institutions.”

doc.ai is developing a new platform for established medical companies, which will enable patients to have personalized, AI-powered conversations about their health at any time. By leveraging these conversations with the “robo-doctor”, patients would achieve better health outcomes from consultations with their physician.

doc.ai's AI technology personalizes conversations with patients on their health data via a mobile app. In order to power its platform and incentivize the community, doc.ai will create ERC-20 based digital tokens, named Neurons (NRNs).

The startup will sell and issue Simple Agreements for Future Tokens (SAFTs), which will convert into NRNs upon the launch of the platform. doc.ai completed the initial sale of SAFTs earlier this month, raising approximately $2.3 million. The round was led by Pantera Capital.

The crowdsale process will kick off on September 28, 2017. According to the terms of the token sale, a total of 860 million NRN will be created, with one NRN representing 100 neurons in the human brain. Approximately 37% of the total number of NRNs is expected to be sold in the SAFT offering.

doc.ai plans to use the funds raised from the token sale to further develop its platform and technology.

Next Steps

doc.ai plans to roll out three natural language processing modules over the course of next 12 months:

• Robo-Genomics
• Robo-Hematology
• Robo-Anatomics

Of these, Robo-Hematology was unveiled on July 24, 2017 at Deloitte University in Dallas, Texas. doc.ai is working with Deloitte Life Sciences and Healthcare to test this solution.

“doc.ai's AI-based doctors provide answers to health questions using an AI-powered platform,” said Rajeev Ronanki, Deloitte Consulting LLP principal of Life Sciences and Health Care. “Platforms like these open new possibilities for patients and medical organizations by providing more personalized, intelligent healthcare. We are excited to collaborate with doc.ai and to be at the forefront of this technology.”